Problem with supplies of Teva lamotrigine
Teva lamotrigine dispersible drugs are currently unavailable in 5mg, 25mg and 100mg strengths. This is due to problems with the manufacture of the drug.
The 5mg tablets are expected to be back in stock from the week commencing 13 November 2017, but Teva do not yet have a confirmed date for when the 25mg and 100mg strengths will be available.
Switching between different versions of same drug
Guidance on prescribing anti-epileptic medication classes lamotrigine as a category 2 epilepsy drug. This means that a doctor should decide with an individual whether to stay on the same version of the drug, or whether it is ok to switch between different versions of the drug.
Epilepsy Society's medical director Professor Ley Sander said: 'If you are taking Teva lamotrigine, please consult your GP in plenty of time before your prescription runs out, so that you can consider switching to a different version of lamotrigine.
'Teva lamotrigine is still available in the non-dispersible form which has the same bioequivalence as the dispersible tablets, and should not present a problem.
'If you are concerned that switching to a different version of your medication may cause you problems, please discuss these worries with your GP.'